TERLIPRESSINE ALTAN 1 mg/8,5 mL, solution injectable — 5 ampoule(s) en verre de 8,5 ml
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400955075813 -
CIP7
5507581 -
CIS
68819052
What the source publishes
- Holder
- ALTAN PHARMACEUTICALS (ESPAGNE)
- Active ingredients
- TERLIPRESSINE, ACÉTATE DE TERLIPRESSINE
- Form
- solution injectable
- Package
- 5 ampoule(s) en verre de 8,5 ml
- Routes
- intraveineuse
- Administrative status
- authorised
- Supply regime
- réservé à l'usage HOSPITALIER ; réservé à l'usage en situation d'urgence selon l'article R5121-96 du code de la santé publique ; liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2020-08-24
- Prescription
- Prescription or restricted
Names this record is found by
- TERLIPRESSINE ALTAN 1 mg/8,5 mL, solution injectable — 5 ampoule(s) en verre de 8,5 ml
- TERLIPRESSINE ALTAN 1 mg/8,5 mL, solution injectable
- TERLIPRESSINE
- ACÉTATE DE TERLIPRESSINE
Complete source data
{
"cis": "68819052",
"cip7": "5507581",
"form": "solution injectable",
"name": "TERLIPRESSINE ALTAN 1 mg/8,5 mL, solution injectable — 5 ampoule(s) en verre de 8,5 ml",
"cip13": "3400955075813",
"holder": "ALTAN PHARMACEUTICALS (ESPAGNE)",
"routes": [
"intraveineuse"
],
"holders": [
"ALTAN PHARMACEUTICALS (ESPAGNE)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "2020-08-24",
"compositions": [
{
"name": "TERLIPRESSINE",
"nature": "FT",
"strength": "0,85 mg",
"linkageNumber": "1",
"substanceCode": "42124",
"dosageReference": "une ampoule de 8,5 mL",
"pharmaceuticalElement": "solution"
},
{
"name": "ACÉTATE DE TERLIPRESSINE",
"nature": "SA",
"strength": "1 mg",
"linkageNumber": "1",
"substanceCode": "60920",
"dosageReference": "une ampoule de 8,5 mL",
"pharmaceuticalElement": "solution"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "réservé à l'usage HOSPITALIER ; réservé à l'usage en situation d'urgence selon l'article R5121-96 du code de la santé publique ; liste I",
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "TERLIPRESSINE ALTAN 1 mg/8,5 mL, solution injectable",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-15",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "5 ampoule(s) en verre de 8,5 ml",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2021-02-04",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"TERLIPRESSINE",
"ACÉTATE DE TERLIPRESSINE"
],
"authorisationProcedure": "Procédure décentralisée",
"prescriptionConditions": [
"réservé à l'usage HOSPITALIER",
"réservé à l'usage en situation d'urgence selon l'article R5121-96 du code de la santé publique",
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400955075813"